(Q42229891)

19 October 2017

title

Autoantibodies to IL-17A may be correlated with the severity of mucocutaneous candidiasis in APECED patients (English)

1 reference

19 October 2017

1 reference

1 reference

Adrien Katalin Sarkadi

1

1 reference

19 October 2017

Szilvia Taskó

2

1 reference

19 October 2017

Gabriella Csorba

3

1 reference

19 October 2017

Beáta Tóth

4

1 reference

19 October 2017

Melinda Erdős

5

1 reference

19 October 2017

László Maródi

6

1 reference

19 October 2017

publication date

4 February 2014

1 reference

Journal of Clinical Immunology

19 October 2017

published in

1 reference

19 October 2017

volume

34

1 reference

19 October 2017

issue

2

1 reference

19 October 2017

page(s)

181-193

1 reference

Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients.

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Immunity to infection in IL-17-deficient mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

IL-22 defines a novel immune pathway of antifungal resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Nomenclature for the description of human sequence variations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Schmidt's syndrome - Case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: clinical and pathogenetic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

A multi-centre study of efficacy and safety of Intratect®, a novel intravenous immunoglobulin preparation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Local and systemic host defense mechanisms against Candida: immunopathology of candidal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Molecular mechanisms of mucocutaneous immunity against Candida and Staphylococcus species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Autoantibodies against Type I Interferons as an Additional Diagnostic Criterion for Autoimmune Polyendocrine Syndrome Type I

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Autoimmune polyendocrine syndrome type 1 (APS I) in Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Intravenous immunoglobulin: an update on the clinical use and mechanisms of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Impaired TH17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Organ-specific and non-organ-specific autoantibodies in children and young adults with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a model disease to study molecular aspects of endocrine autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Inborn errors of mucocutaneous immunity to Candida albicans in humans: a role for IL-17 cytokines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Chronic mucocutaneous candidiasis and oesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Herpes in STAT1 gain-of-function mutation [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Chronic candidosis and oral cancer in APECED-patients: production of carcinogenic acetaldehyde from glucose and ethanol by Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Autoimmune polyendocrine syndrome type 1: case report and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

IL-22 in antifungal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Microbiological screening of Irish patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy reveals persistence of Candida albicans strains, gradual reduction in susceptibility to azoles, and incidences of clinical signs of oral c

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Increased IL-17A secretion in response to Candida albicans in autoimmune polyendocrine syndrome type 1 and its animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Intravenous Immunoglobulins in Autoimmune and Inflammatory Diseases: A Mechanistic Perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10875-014-9987-5

Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes.

21 January 2018

1 reference

12 December 2020

Growth hormone deficiency in autoimmune polyglandular disease type 1

1 reference

12 December 2020

Influence of IVIg therapy on autoantibody titers to desmoglein 1 in patients with pemphigus foliaceus

1 reference

12 December 2020

Novel sequence variation of AIRE and detection of interferon-omega antibodies in early infancy

1 reference

12 December 2020

Oral and oesophageal squamous cell carcinoma – A complication or component of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED, APS-I)

1 reference

12 December 2020

10.1007/S10875-014-9987-5

Identifiers

DOI

1 reference

Dimensions Publication ID

19 October 2017

1018891627

0 references

1 reference